Depression
Showing NaN - NaN of 27
Depression Trial in United States (Pharmacogenetic testing, Clinical decisions support)
Recruiting
- Depression
- Pharmacogenetic testing
- Clinical decisions support
-
Wilmington, Delaware
- +13 more
Jul 21, 2023
Depression Trial in Jacksonville (Ketamine Hydrochloride, Placebo)
Not yet recruiting
- Depression
- Ketamine Hydrochloride
- Placebo
-
Jacksonville, FloridaMayo Clinic Florida
Mar 26, 2023
Depressive Disorder, Depression, Depression, Postpartum Trial in United States (Ganaxolone, Placebo)
Depression, Acute Pain, Chronic Pain Trial in United States (Pharmacogenetic testing, Clinical decisions support)
Recruiting
- Depression
- +2 more
- Pharmacogenetic testing
- Clinical decisions support
-
Wilmington, Delaware
- +12 more
Jan 6, 2023
Bipolar I Disorder, Mania, Depression Trial in Worldwide (Cariprazine, Placebo)
Completed
- Bipolar I Disorder
- +2 more
- Cariprazine
- Placebo
-
Little Rock, Arkansas
- +111 more
Dec 12, 2022
Depression, MDD Trial in Jacksonville, Rochester (Clinical decision support tool)
Completed
- Depression
- Major Depressive Disorder
- Clinical decision support tool
-
Jacksonville, Florida
- +1 more
Dec 9, 2022
MDD, Treatment Resistant Depression, Depression Trial in United States (AXS-05)
Completed
- Major Depressive Disorder
- +2 more
- AXS-05 (dextromethorphan and bupropion) oral tablets
-
Phoenix, Arizona
- +50 more
Sep 16, 2022
Depression, MDD Trial in United States (AXS-05, Placebo)
Completed
- Depression
- Major Depressive Disorder
- AXS-05
- Placebo
-
Phoenix, Arizona
- +42 more
Sep 22, 2021
Depression Trial in Jacksonville (Tele-psychiatry consult)
Withdrawn
- Depression
- Tele-psychiatry consult
-
Jacksonville, FloridaMayo Clinic in Florida
Feb 5, 2019
Bipolar Disorder, Depression Trial in Worldwide (Cariprazine, Placebo)
Completed
- Bipolar Disorder
- Depression
- Cariprazine
- Placebo
-
Little Rock, Arkansas
- +73 more
Jan 10, 2019
Depressive Disorder, Depression, Depressive Disorder, Major Trial in Worldwide (OPC-34712, Escitalopram, Fluoxetine)
Depressive Disorder, Depression, Depressive Disorder, Major Trial in Worldwide (Brexpiprazole, Seroquel XR, Placebo)
Completed
- Depressive Disorder
- +4 more
- Brexpiprazole
- +2 more
-
Birmingham, Alabama
- +75 more
May 10, 2018
Sexual Dysfunctions, Psychological, Depression Trial in United States (flibanserin 50 mg to 100 mg qhs, flibanserin 100 mg qhs,
Terminated
- Sexual Dysfunctions, Psychological
- Depression
- flibanserin 50 mg to 100 mg qhs
- +2 more
-
Costa Mesa, California
- +41 more
Jul 14, 2016
Cognitive/Functional Effects, Delirium, Depression Trial in United States (dietary supplement, drug, other)
Completed
- Cognitive/Functional Effects
- +4 more
- vitamin E
- +2 more
-
Scottsdale, Arizona
- +14 more
Jul 12, 2016
Depressive Disorder, Depression, Depressive Disorder, Major Trial in Worldwide (OPC-34712 + ADT, Placebo + ADT)
Completed
- Depressive Disorder
- +4 more
- OPC-34712 + ADT
- Placebo + ADT
-
Birmingham, Alabama
- +70 more
Nov 30, 2015
Depressive Disorder, Depression, Depressive Disorder, Major Trial in Worldwide (OPC-34712 + ADT, Placebo + ADT)
Completed
- Depressive Disorder
- +4 more
- OPC-34712 + ADT
- Placebo + ADT
-
Arcadia, California
- +56 more
Oct 26, 2015
Depression Trial in Worldwide (Placebo matching with BMS-820836, BMS-820836)
Terminated
- Depression
- Placebo matching with BMS-820836
- BMS-820836
-
Birmingham, Alabama
- +143 more
Sep 23, 2015
MDD, Depression Trial in India, United States (TC-5214, Placebo)
Completed
- Major Depressive Disorder
- Depression
- TC-5214
- Placebo
-
Tuscaloosa, Alabama
- +50 more
Mar 14, 2014
MDD, MDD, Depression Trial in Puerto Rico, United States (TC-5214, Placebo)
Completed
- Major Depressive Disorder
- +2 more
- TC-5214
- Placebo
-
Birmingham, Alabama
- +93 more
Mar 14, 2014